Company Data
Harmony Biosciences Holdings Inc.
Ticker
HRMY
Current Price
$35.29 -0.76%
Market Cap
$2.0B
Price Target
Refer to Report
Volume
256.4K
52wk Range
$25.52 - $40.93
Overview
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The companys product WAKIX pitolisant is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.